IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis

Published on February 20, 2025

The Ineos Oxford Institute for antimicrobial research (IOI) has awarded £5 million to a group of 17 interdisciplinary researchers from Oxford University to develop new therapies for drug-resistant tuberculosis.